🇺🇸 Bronchipret in United States

16 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Foetal Exposure During Pregnancy — 2 reports (12.5%)
  2. Haemangioma Congenital — 2 reports (12.5%)
  3. Infection — 2 reports (12.5%)
  4. Neutropenia — 2 reports (12.5%)
  5. Pneumonia — 2 reports (12.5%)
  6. Respiratory Depression — 2 reports (12.5%)
  7. Acute Kidney Injury — 1 report (6.25%)
  8. Agranulocytosis — 1 report (6.25%)
  9. Anuria — 1 report (6.25%)
  10. Apnoea — 1 report (6.25%)

Source database →

Other Respiratory approved in United States

Frequently asked questions

Is Bronchipret approved in United States?

Bronchipret does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Bronchipret in United States?

Dr. Frank Behrens is the originator. The local marketing authorisation holder may differ — check the official source linked above.